Genetic Architecture of Cerebral Edema after Stroke
中风后脑水肿的遗传结构
基本信息
- 批准号:10666702
- 负责人:
- 金额:$ 47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-15 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAgeAttenuatedBiologicalBiological FactorsBiological MarkersBiologyBlood PressureBrain EdemaBrain InjuriesBrain hemorrhageCerebral EdemaCerebrospinal FluidCerebrumCessation of lifeClinicalDataData SetDatabasesDeteriorationDevelopmentDimensionsDisparateEdemaEnrollmentExhibitsFundingGenesGeneticGenetic studyGenomicsGenotypeGlucoseGoalsGrowthHemorrhageHeritabilityHeterogeneityHospitalsHumanHyperglycemiaHypertensionImageImpairmentInfarctionInjuryInterventionIntracranial PressureIon ChannelIschemiaIschemic StrokeKnowledgeLinkMalignant - descriptorMeasurementMeasuresMediatingMediatorMendelian randomizationMicrovascular DysfunctionModelingMolecularMolecular TargetNational Institute of Neurological Disorders and StrokeNeurologicNeuronsOutcomeParticipantPathologicPathway interactionsPatientsPhenotypePopulationQuantitative GeneticsRecoveryRenal functionReperfusion TherapyRiskSample SizeSeveritiesSourceStrokeSwellingTimeTissuesTraumaTraumatic Brain InjuryWaterWorkX-Ray Computed Tomographyacute strokeanalysis pipelineannotation systemautomated analysisautomated image analysisbioinformatics toolblood-brain barrier permeabilizationbrain tissuebrain volumecohortdensitydrug discoveryeffective therapyempowermentfollow-upgene discoverygenetic architecturegenetic informationgenetic variantgenome wide association studygenomic dataimaging geneticsimproved outcomeinjuredinsightinterpatient variabilitynovelpatient variabilitypost strokepreventquantitative imagingrepositoryresponsesexstroke outcomestroke patientstroke recoverysuccesstargeted treatmenttraittumoruptakewhite matter injury
项目摘要
PROJECT SUMMARY
Cerebral edema is a major contributor to neurological deterioration and the leading cause of in-hospital death
after stroke. This pathologic water accumulation results in an increase in brain volume that can be measured
after most hemispheric strokes. This brain swelling not only raises the risk of cerebral herniation but also impairs
stroke recovery as much as infarct growth does. However, the key biologic factors and molecular mechanisms
that mediate formation of cerebral edema remain poorly defined. This knowledge gap has hindered development
of targeted interventions to mitigate the consequences of edema in conditions as diverse as brain trauma,
tumors, and hemorrhagic as well as ischemic strokes. There is significant variability between patients, with some
exhibiting malignant edema and others with none to mild swelling despite similar stroke sizes and severities. The
central objective of this proposal is to integrate imaging with genetics to identify key biologic pathways and
mediators implicated in cerebral edema. We will acquire serial CT scans from 3,506 patients in an NINDS-funded
stroke genetics study (GENISIS) and 1,000 being enrolled in an ERA-NET NEURON-funded study (iBioStroke).
We will apply automated analysis pipelines to obtain quantitative multi-dimensional measurements of edema
severity. Our primary biomarker is the displacement of cerebrospinal fluid (ΔCSF) that serves as a surrogate for
the volume of swelling that has developed after stroke. However, we will also measure hemispheric CSF ratio
and lesional water uptake as additional edema phenotypes. We will model edema formation (in relation to time
from stroke onset) to evaluate the degree to which biologic factors, such as age, sex, glucose, blood pressure,
and renal function, influence edema formation. Our central hypothesis is that inter-patient variability in edema
formation can be linked to both targetable clinical factors such as hyperglycemia and informative genetic
differences. Our preliminary data has suggested that ΔCSF has a significant heritable component. Specific Aim
1 seeks to quantify the relationship of key clinical factors, such as hyperglycemia and blood pressure, to edema
formation. We will leverage genomic data to further dissect which factors are causative in edema formation,
using Mendelian randomization. We will also quantify the impact of edema and hemorrhagic transformation on
stroke recovery. Specific Aim 2 will identify genes and pathways associated with cerebral edema after stroke. It
will employ genome-wide association (GWAS) approaches with multiple edema phenotypes in this large cohort.
We will further prioritize genes and pathways using functional annotation tools. Specific Aim 3 will dissect shared
versus edema-specific injury mechanisms by analyzing edema in relation to traits such as hemorrhagic
transformation, white matter injury and small-vessel disease. It will leverage large existing datasets to boost the
power of gene discovery from Aim 2. Once complete, this work will provide the first comprehensive picture of
the genetic architecture of cerebral edema after stroke and provide unbiased, novel insights into molecular
targets that can inform drug discovery.
项目摘要
大脑水肿是神经定义的主要因素,是院内死亡的主要原因
中风后。这种病理水的积累导致大脑体积的增加,可以测量
经过大多数半球的中风。这种大脑肿胀不仅增加了大脑疝的风险,还会损害
中风恢复与梗塞增长一样多。但是,关键的生物学因素和分子机制
大脑水肿的介导形成仍然很差。这种知识差距阻碍了发展
有针对性的干预措施以减轻水肿的后果,如脑创伤等潜水员
肿瘤,出血性和缺血性中风。患者之间存在显着差异,有些
表现出恶性水肿和其他人,没有一个轻度肿胀的目的地类似的中风大小和严重性。这
该建议的核心目的是将成像与遗传学整合,以识别关键的生物学途径和
在大脑水肿中实施的介质。我们将从Ninds资助的3,506名患者中获取连续的CT扫描
中风遗传学研究(GENISI)和1,000名由ERA-NET神经元资助的研究(IBIOSTROKE)纳入了1,000名。
我们将应用自动分析管道以获得水肿的定量多维测量
严重程度。我们的主要生物标志物是脑脊液(ΔCSF)的位移,它是替代的
中风后发生的肿胀量。但是,我们还将测量半球CSF比率
和病变的水吸收作为其他水肿表型。我们将建模水肿形成(与时间有关
从中风开始),以评估年龄,性别,葡萄糖,血压等生物学因素的程度
和肾功能,影响水肿形成。我们的中心假设是水肿间变异性
形成可以与诸如高血糖和信息通用的临床因素有关
差异。我们的初步数据表明ΔCSF具有重要的可遗传成分。具体目标
1试图量化关键临床因素(例如高血糖和血压)与水肿的关系
形成。我们将利用基因组数据进一步剖析浮肿形成中哪些因素,
使用孟德尔随机化。我们还将量化水肿和出血转化对
中风恢复。特定的目标2将识别中风后与脑水肿相关的基因和途径。它
将在这个大型队列中采用与多种水肿表型采用全基因组关联(GWAS)方法。
我们将使用功能注释工具进一步优先考虑基因和途径。特定目标3将剖析共享
通过分析与出血性特征有关的水肿与水肿特异性损伤机制
转化,白质损伤和小血管疾病。它将利用大型现有数据集来提高
AIM 2从AIM 2发现基因的力量。一旦完成,这项工作将提供第一张全面的图片
中风后脑水肿的遗传结构,并提供了对分子的无偏新见解
可以告知药物发现的目标。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Automated Quantification of Compartmental Blood Volumes Enables Prediction of Delayed Cerebral Ischemia and Outcomes After Aneurysmal Subarachnoid Hemorrhage.
室室血容量的自动定量可以预测迟发性脑缺血和动脉瘤性蛛网膜下腔出血后的结果。
- DOI:10.1016/j.wneu.2022.10.105
- 发表时间:2023
- 期刊:
- 影响因子:2
- 作者:Yuan,JaneY;Chen,Yasheng;Jayaraman,Keshav;Kumar,Atul;Zlepper,Zach;Allen,MichelleL;Athiraman,Umeshkumar;Osbun,Joshua;Zipfel,Gregory;Dhar,Rajat
- 通讯作者:Dhar,Rajat
Collateral Status, Reperfusion, and Cerebral Edema After Thrombectomy for Stroke.
中风血栓切除术后的侧支状况、再灌注和脑水肿。
- DOI:10.1007/s12028-023-01901-3
- 发表时间:2024
- 期刊:
- 影响因子:3.5
- 作者:Dhar,Rajat
- 通讯作者:Dhar,Rajat
Collateral Flow: Prolonging the Ischemic Penumbra.
侧支血流:延长缺血半暗带。
- DOI:10.1007/s12975-023-01126-8
- 发表时间:2023
- 期刊:
- 影响因子:6.9
- 作者:Dhar,Rajat;Yu,Wengui;Yenari,Midori;Lee,Jin-Moo
- 通讯作者:Lee,Jin-Moo
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rajat Dhar其他文献
Rajat Dhar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rajat Dhar', 18)}}的其他基金
Genetic Architecture of Cerebral Edema after Stroke
中风后脑水肿的遗传结构
- 批准号:
10446825 - 财政年份:2022
- 资助金额:
$ 47万 - 项目类别:
GENETICS AND PREDICTION OF CEREBRAL EDEMA AFTER HEMISPHERIC STROKE
半球卒中后脑水肿的遗传学和预测
- 批准号:
9754265 - 财政年份:2017
- 资助金额:
$ 47万 - 项目类别:
GENETICS AND PREDICTION OF CEREBRAL EDEMA AFTER HEMISPHERIC STROKE
半球卒中后脑水肿的遗传学和预测
- 批准号:
10020442 - 财政年份:2017
- 资助金额:
$ 47万 - 项目类别:
GENETICS AND PREDICTION OF CEREBRAL EDEMA AFTER HEMISPHERIC STROKE
半球卒中后脑水肿的遗传学和预测
- 批准号:
10237306 - 财政年份:2017
- 资助金额:
$ 47万 - 项目类别:
GENETICS AND PREDICTION OF CEREBRAL EDEMA AFTER HEMISPHERIC STROKE
半球卒中后脑水肿的遗传学和预测
- 批准号:
9386514 - 财政年份:2017
- 资助金额:
$ 47万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Regulation and function of aged hematopoietic stem cell (HSC) niche
衰老造血干细胞(HSC)生态位的调节和功能
- 批准号:
10723396 - 财政年份:2023
- 资助金额:
$ 47万 - 项目类别:
Redox stress resilience in aging skeletal muscle
衰老骨骼肌的氧化还原应激恢复能力
- 批准号:
10722970 - 财政年份:2023
- 资助金额:
$ 47万 - 项目类别:
Contribution of Vitamin D Deficiency to Pathological Progression in Models of Cerebral Hypoperfusion
维生素 D 缺乏对脑低灌注模型病理进展的影响
- 批准号:
10725358 - 财政年份:2023
- 资助金额:
$ 47万 - 项目类别:
Developing a PIV5-based human metapneumovirus (HMPV) vaccine
开发基于 PIV5 的人类偏肺病毒 (HMPV) 疫苗
- 批准号:
10698491 - 财政年份:2023
- 资助金额:
$ 47万 - 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 47万 - 项目类别: